Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy

Busra Yilmaz,1 Efsun Somay,2 Ugur Selek,3,4 Erkan Topkan5 1Department of Dentomaxillofacial Radiology, Faculty of Dentistry, Baskent University, Ankara, Turkey; 2Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey; 3Department of Radiation Oncology,...

Full description

Bibliographic Details
Main Authors:	Yilmaz B, Somay E, Selek U, Topkan E
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-10-01
Series:	Therapeutics and Clinical Risk Management
Subjects:	concurrent chemoradiotherapy head and neck cancers systemic immune-inflammation index tooth extraction
Online Access:	https://www.dovepress.com/pretreatment-systemic-immune-inflammation-index-predict-needs-for-teet-peer-reviewed-fulltext-article-TCRM

Similar Items

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
by: Busra Yilmaz, et al.
Published: (2023-04-01)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
by: Qiuji Wu, et al.
Published: (2021-10-01)

Competing Morbidities In Advanced Head And Neck Squamous Cell Carcinoma Concurrent Chemoradiotherapy: A Strong Implication Of A Multidisciplinary Team Approach
by: Lazzari G, et al.
Published: (2019-11-01)

Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers
by: Yoon Kyoung So, et al.
Published: (2023-07-01)

Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
by: Erkan Topkan, et al.
Published: (2020-11-01)

Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy
by: Yu-Ching Lin, et al.
Published: (2022-02-01)

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
by: Hundo Cho, et al.
Published: (2022-05-01)

Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy
by: Gunjesh Kumar Singh, et al.
Published: (2017-03-01)

Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision
by: Chao-Hung Wang, et al.
Published: (2022-06-01)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
by: Hiromichi Shirasu, et al.
Published: (2020-03-01)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
by: Yeona Cho, et al.
Published: (2018-10-01)

Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer
by: Yu-Ching Lin, et al.
Published: (2021-08-01)

Outcome in radiographic complete regression of unresectable head and neck cancer with carotid artery encasement from induction chemotherapy followed by concurrent chemoradiotherapy: Case reports
by: Federico Ampil, et al.
Published: (2019-06-01)

Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients
by: Erkan Topkan, et al.
Published: (2023-07-01)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
by: Muhammad Shahid Iqbal, et al.
Published: (2017-04-01)

Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy
by: Umur Anil Pehlivan, et al.
Published: (2023-10-01)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
by: Jantien Hoek, et al.
Published: (2016-02-01)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
by: Pei-Wei Huang, et al.
Published: (2018-04-01)

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients
by: Efsun Somay, et al.
Published: (2024-01-01)

Role of addition of chemotherapy to palliative radiotherapy protocol: A review of literature and experience from a tertiary cancer center of India
by: Pavan Deepak Mandigala Venkata Ramana, et al.
Published: (2023-01-01)

Can zinc supplementation widen the gap between control and complications in head and neck cancer patients treated with concurrent chemo-radiotherapy
by: Mohsin Khan, et al.
Published: (2019-01-01)

Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
by: Rhiannon Mellor, et al.
Published: (2024-02-01)

To compare the effect of conventional radiotherapy versus concurrent chemoradiotherapy on the thyroid gland after external beam radiotherapy in head-and-neck carcinoma
by: Surabhi Gupta, et al.
Published: (2021-01-01)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
by: Hayashi N, et al.
Published: (2021-11-01)

Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index
by: Efsun Somay, et al.
Published: (2023-12-01)

Patients with Spondylodiscitis following Chemoradiotherapy for Head and Neck Cancer in a Portuguese Cancer Hospital: A Case Report
by: Diana Pessoa, et al.
Published: (2024-04-01)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
by: Haksoyler V, et al.
Published: (2021-07-01)

An observational comparative study of weekly and 3 weekly concurrent cisplatin-based chemoradiotherapy in locally advanced head-and-neck cancer in a peripheral medical college
by: Ritika Biswas, et al.
Published: (2023-01-01)

Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy
by: Takao Hamamoto, et al.
Published: (2023-07-01)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
by: Raminta Stuopelytė, et al.
Published: (2023-04-01)

Nutritional status of patients undergoing concurrent chemoradiotherapy for malignant tumor and its influencing factors
by: WANG Peng, WANG Zheng, ZHANG Lichuan, WANG Yujie, LU Qian
Published: (2024-02-01)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
by: Yuanxiu Yin, et al.
Published: (2022-07-01)

The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
by: Igor Sirák, et al.
Published: (2008-01-01)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Kailin Wang, et al.
Published: (2019-05-01)

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
by: Juan L. Callejas-Valera, et al.
Published: (2022-05-01)

Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan
by: Aleksandra Kapała, et al.
Published: (2021-05-01)

High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
by: Kucuk A, et al.
Published: (2022-04-01)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
by: Haonan Liu, et al.
Published: (2022-12-01)

Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions
by: Hiroshi Matsuyama, et al.
Published: (2022-11-01)